A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
about
Therapeutic Antibodies against Intracellular Tumor AntigensEffects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes.
P2860
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A therapeutic T cell receptor ...... PRAME peptide/HLA-I antigens.
@en
type
label
A therapeutic T cell receptor ...... PRAME peptide/HLA-I antigens.
@en
prefLabel
A therapeutic T cell receptor ...... PRAME peptide/HLA-I antigens.
@en
P2093
P2860
P50
P356
P1476
A therapeutic T cell receptor ...... d PRAME peptide/HLA-I antigens
@en
P2093
Aaron Y Chang
David A Scheinberg
Melissa D Mathias
Michael Curcio
Ronald C Hendrickson
Tatyana Korontsvit
Victoriya Zakhaleva
P2860
P304
P356
10.1172/JCI92335
P407
P577
2017-06-19T00:00:00Z